CAMBRIDGE, Mass., April 28 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its presentations
at Deutsche Bank's 31st Annual Health Care Conference on May 2, 2006 and at
Morgan Stanley's Global Healthcare Unplugged Conference on May 4, 2006.
Joshua Boger, Ph.D., Chairman, President and Chief Executive Officer of
Vertex, will present at the Deutsche Bank Health Care Conference on
Tuesday, May 2, 2006 at 4:00 p.m. EDT and will also participate in an HCV
Panel at 4:45 p.m. EDT.
Ian Smith, Executive Vice President and Chief Financial Officer of
Vertex, will present at the Morgan Stanley Global Healthcare Conference.
The presentation and discussion will be conducted on Thursday, May 4, 2006
at 8:00 a.m. EDT.
The presentations will be webcast live and may be accessed by visiting
the Vertex website at http://www.vrtx.com. A replay of the webcasts will
also be available on the Company's website for two weeks following the
presentations. To access the webcasts, go to Vertex's website and select
the 'Deutsche Bank 31st Annual Health Care Conference' or the 'Deutsche
Bank HCV Panel' or the 'Morgan Stanley 2006 Global Healthcare Unplugged
Conference' from the 'Events Calendar.' To ensure a timely connection, it
is recommended that users register at least 15 minutes prior to the
scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. In collaboration
with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor,
Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex, +1-617-444-6755
|
